Related Experiment Video
Updated: Jan 30, 2026

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells
Published on: October 17, 2025
Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs
Timo W M De Groof1, Vladimir Bobkov2, Raimond Heukers3
1Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit, De Boelelaan 1108, 1081 HZ, Amsterdam, the Netherlands.
Camelid-derived nanobodies offer a powerful approach for targeting G protein-coupled receptors (GPCRs). These antibody fragments excel at detecting, stabilizing, modulating, and therapeutically targeting GPCRs due to their unique structural properties.
Area of Science:
- Biochemistry and Molecular Biology
- Immunology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and are crucial targets in numerous physiological and pathological processes.
- While small molecules are common therapeutics, biologicals like antibodies and antibody fragments are emerging as alternative strategies for GPCR modulation.
- Camelid-derived heavy chain-only antibodies, known as nanobodies (VHHs or sdAbs), offer unique advantages for targeting membrane proteins.
Purpose of the Study:
- To review the application of nanobodies for the detection, stabilization, modulation, and therapeutic targeting of GPCRs.
- To highlight the favorable characteristics of nanobodies, such as their small size and unique antigen-binding loops, for developing selective and potent GPCR-binding molecules.
- To explore the potential of nanobodies as tools for studying GPCR function, including intracellular expression capabilities.
Main Methods:
- Literature review focusing on studies utilizing nanobodies against GPCRs.
- Analysis of nanobody structural features and their implications for GPCR interaction.
- Examination of nanobody applications in GPCR detection, stabilization, modulation, and therapeutics.
Main Results:
- Nanobodies demonstrate significant potential for detecting, stabilizing, and modulating GPCR activity.
- Their small size, unique structure, and protruding loops facilitate the development of selective and potent GPCR-targeting molecules.
- Nanobodies can be expressed intracellularly, enabling novel approaches to studying GPCR function.
Conclusions:
- Nanobodies are versatile tools for GPCR research and therapeutic development.
- Their unique properties make them ideal for imaging, stabilizing, and modulating GPCR function.
- The application of nanobodies broadens the scope of therapeutic strategies for GPCR-related diseases.
More Related Videos
Related Concept Videos
Nuclear Stability
To hold positively charged protons together...
RNA Stability
GPCRs Regulate Adenylyl Cylase Activity
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
Stability of structures
Pole and System Stability
Simple poles are unique roots of the denominator polynomial. Each simple pole corresponds to a distinct solution to the system's characteristic equation, typically resulting in exponential decay terms in the system's...

